DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting April 1, 2013 • 9:27 AM EDT
DelMar Pharmaceuticals to Present at the 25th Annual ROTH Capital Partners Growth Stock Conference March 11, 2013 • 8:00 AM EDT
DelMar Pharmaceuticals Announces Completion Of $10.5 Million Oversubscribed Offering And Appointment Of Investor Relations Consultant March 7, 2013 • 8:00 AM EST
DelMar Pharmaceuticals Announces Appointment of John K. Bell to Board of Directors February 28, 2013 • 1:21 PM EST
DelMar Pharmaceuticals Announces $1.6 Million Closing in Private Placement February 25, 2013 • 7:00 AM EST
DelMar Pharmaceuticals Announces $1.0 Million Third Closing in Private Placement February 11, 2013 • 8:30 AM EST
DelMar Pharmaceuticals Announces $1.5 Million Second Closing in Private Placement January 31, 2013 • 6:07 PM EST
DelMar Pharmaceuticals Announces Acquisition and $5.4 Million Private Placement to Advance Novel Cancer Therapies January 25, 2013 • 12:50 PM EST